<DOC>
	<DOCNO>NCT00860340</DOCNO>
	<brief_summary>To determine beneficial effect spironolactone patient congestive heart failure part due intrinsic inotropic action . Randomized , two group placebo control , single blind study .</brief_summary>
	<brief_title>Hemodynamic Effects Spironolactone Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>CHF 21 80 year Serum creatinine &lt; 2 mg/dL Serum potassium 2.7 4.5 mg/dL measure within past 4 week Less 21 year Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Echocardiographs</keyword>
</DOC>